ArticleFrontiers in oncology2023

Anti-cancer treatment within two weeks serves as a risk factor for clinical outcomes among cancer patients with COVID-19.

Jia-Xin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.